
Asia-Pacific Next-generation Diagnostics Outlook, 2023
Description
Asia-Pacific Next-generation Diagnostics Outlook, 2023
The Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth
The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus on breakthrough innovation, diagnostic services must be revamped to meet reduced price points for low-resource settings.
The pandemic led to a greater focus on preventive diagnosis. Innovation in product development, a focus on care delivery and business models, and the need for more convenient sampling are leading to a paradigm shift to minimally invasive tests. Global IVD powerhouses remain at the vanguard of this transformation. Prominent market participants are Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Siemens Healthineers, and Sysmex Corporation, while regional IVD powerhouses are making a strategic shift to leverage the platform-as-a-service business model, implying momentum in secured and connected open development platforms to support rapid and standardized assay development. Trends point toward a focus on infectious diseases outside COVID-19, molecular oncology, cardiovascular disease, and diabetes, with an emerging focus on noninvasive prenatal testing (NIPT).
Table of Contents
57 Pages
- Study Highlights
- Top Next-generation Diagnostics Industry Predictions-2023
- Why is it Increasingly Difficult to Grow?
- The Strategic Imperative 8
- The Impact of the Top 3 Strategic Imperatives on the Next-generation Diagnostics Industry
- Growth Opportunities Fuel the Growth Pipeline Engine
- Segmentation
- Growth Environment
- Top 5 Global Economic Highlights-2023
- Global GDP Growth Snapshot
- Advanced Economies' Predictions-2023
- Emerging Economies' Predictions-2023
- Regional Risks and Policy Direction-2023
- Supply Chain Disruptions-Impact Analysis
- Innovation-Impact Analysis
- Commercial Success-Impact Analysis
- Revenue Forecast by Segment
- Competitive Environment
- Revenue Share
- Revenue Share Analysis
- Revenue Forecast by Country
- Revenue Forecast Analysis by Country
- Prediction 1-Infectious Disease Testing will Largely Transition to POC Rapid Tests
- Prediction 2-Comprehensive POCT Solutions in Diabetes Care will Proliferate to Empower Fast Clinical Decision Making
- Prediction 3-A Spike in Population-sequencing Efforts will Drive NGS Market Expansion
- Prediction 4-Demand for Cardiac Biomarker Testing in Hospitals will Drive Clinical Chemistry and Immunoassay Market Growth in China
- Market Snapshot-2023
- Market Snapshot-Clinical Chemistry and Immunoassays
- Market Snapshot-Molecular Diagnostics
- Market Snapshot-POCT
- Growth Opportunity 1: POC Rapid Testing
- Growth Opportunity 2: NIPT
- Growth Opportunity 3: Comprehensive Cancer Genomic Profiling Services
- Conclusions
- Your Next Steps
- Why Frost, Why Now?
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.